Among the half-billion people who have passed through Covid-19's shadow, a quiet and persistent wound remains for roughly one in twenty: the world has lost its scent and flavour. A large international study, published in the British Medical Journal, finds that some 27 million people globally may never fully recover their sense of smell or taste — a loss that is invisible to scanners and absent from headlines, yet quietly reshapes how people eat, remember, and move through the world. The research is both a reckoning with scale and a call to medicine to take seriously what it has long overlooked
Study: 5% of Covid patients face long-term smell and taste loss
Related Coverage
A rare solar eclipse across the UK and Europe captures headlines with dramatic imagery and public celebration, while new…
The New York Times · Aug 13 Total Eclipse Sweeps Across Europe From Iceland to SpainA total solar eclipse crossed Europe from Iceland to Spain, drawing crowds to viewing locations as the moon completely b…
Times of India · Aug 13 Total solar eclipse returns to Spain after 121 years, mesmerizes EuropeA total solar eclipse crossed Spain and Iceland on Wednesday, marking Western Europe's first since 1999 and Spain's firs…
e-flux.com · Aug 13 M-Cult announces 2026–27 artist residencies with open call for Nordic-Baltic creatorsM-Cult opens residency programs in Helsinki with selected international artists exploring urban nature and technology, p…
Bias & Framing
Factual reporting on peer-reviewed research with balanced presentation of findings; minimal bias detected in straightforward health journalism.
Evidence-based reporting that presents research findings with appropriate context and caveats. Uses percentages and recovery rates to provide comprehensive picture. Frames long-term effects as affecting a minority while noting most recover.
Geopolitical Impact
Medical research on COVID-19 long-term effects has no direct geopolitical implications; this is a public health finding affecting 27M people globally.
Economic Lens
5% of Covid-19 patients face persistent smell/taste loss affecting ~27M globally, with women showing lower recovery rates, potentially increasing demand for healthcare services and treatment development.
27 million people globally may experience reduced quality of life, affecting nutrition, food enjoyment, and social dining. This creates demand for specialized medical treatments, therapies, and support services. Potential productivity losses from affected workers and increased healthcare expenditures for households.
Governments may need to allocate research funding for chemosensory dysfunction treatment, establish long-term patient registries for monitoring, integrate smell/taste assessment into post-Covid care protocols, and potentially recognize long-Covid conditions in disability/workers' compensation frameworks. Healthcare systems should develop specialized clinics and treatment guidelines.